Peel Hunt is acting as Joint Rule 3 Adviser, NOMAD and Joint Corporate Broker to Sinclair Pharma PLC on its recommended Cash Offer (effected by means of a Court-sanctioned Scheme of Arrangement) from Huadong Medicine Aesthetics Investment (HongKong) Limited (a wholly owned subsidiary of Huadong Medicine Co., Ltd) of 32 pence in cash for each Sinclair Pharma ordinary share (valuing the entire issued and to be issued ordinary share capital of Sinclair Pharma at c.£167m) as announced on 18th September, 2018.
